Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Immunology Webinars & Conferences

Asia Pacific & Middle East
Canada

Immunology Meet 2024

About Conference


Welcome to the 5th International Conference on Immunology and Immunotherapy, scheduled for December 12-13, 2024, in the vibrant city of Zurich, Switzerland. This premier event brings together leading researchers, clinicians, and industry experts from around the world to share the latest advancements in immunology and immunotherapy. Our conference offers a platform for meaningful discussions, exchange of cutting-edge research, and collaboration that can propel the field to new heights.

Join us for insightful sessions, keynote addresses by renowned experts, and networking opportunities that foster innovation and partnerships. Whether you're an established professional or an emerging researcher, this conference provides an enriching environment to explore new ideas and make valuable connections. We look forward to welcoming you to Zurich and to an exciting two days of scientific discovery and professional growth.

Why to attend?

Attending Immunology Meet 2024 offers a unique opportunity to stay at the forefront of groundbreaking research and clinical practices in immunology. You'll engage with leading experts, gain insights into the latest advancements, and explore innovative solutions that are shaping the future of healthcare. The event also provides valuable networking opportunities with global professionals, fostering collaborations and expanding your professional circle. Don’t miss your chance to be part of transformative discussions that could drive the next wave of innovation in immunotherapy.

Target audience:

  • Immunologists and immunotherapy specialists
  • Clinical and medical researchers
  • Oncologists and cancer immunotherapy professionals
  • Biotechnologists and pharmacologists
  • Healthcare professionals, including MDs, nurses, and allied health practitioners
  • Academic scientists, professors, and university faculty members
  • Laboratory technicians and diagnostic professionals
  • Industry leaders, CEOs, and R&D professionals in pharmaceuticals and biotechnology
  • Regulatory authorities and policy makers in healthcare
  • Medical device and diagnostics manufacturers
  • Students, postdocs, and early-career researchers in immunology and biomedical sciences
  • Patient advocacy groups and nonprofit organizations focusing on immunotherapy

Sessions

Track 1: Advances in Immune System Mechanisms

Explore the latest breakthroughs in understanding immune system functions, including innate and adaptive immunity. This session covers cellular mechanisms, signaling pathways, and molecular interactions that regulate immune responses, providing a foundation for developing new immunotherapies.

Track 2: Cancer Immunotherapy: Current Innovations

This session highlights recent advances in cancer immunotherapy, including CAR-T cell therapy, checkpoint inhibitors, and cancer vaccines. Learn about ongoing clinical trials, challenges in treatment, and emerging technologies that are driving personalized cancer immunotherapy.

Track 3: Autoimmune Diseases and Immunomodulation

Delve into the complexities of autoimmune diseases and the role of immunomodulation in managing them. Topics include novel therapies targeting specific immune pathways, advances in understanding disease etiology, and strategies to minimize immune-related adverse effects.

Track 4: Immunotherapy in Infectious Diseases

This session focuses on immunotherapy's role in combating infectious diseases, from viral to bacterial and parasitic infections. Explore the development of immunotherapeutic agents, including monoclonal antibodies and immune boosters, that target infectious pathogens.

Track 5: Vaccine Development and Immunogenicity

Explore cutting-edge research in vaccine development, focusing on enhancing immunogenicity and long-term protection. This session covers novel adjuvants, delivery systems, and next-generation vaccines for infectious diseases and cancer prevention.

Track 6: Immunogenomics and Personalized Immunotherapy

Learn how advancements in immunogenomics are transforming personalized immunotherapy. This session covers the integration of genomic data with immune profiling to tailor treatments to individual patients, improving outcomes in cancer and autoimmune diseases.

Track 7: Regenerative Medicine and Immunotherapy

This session explores the intersection of regenerative medicine and immunotherapy. Topics include stem cell therapies, tissue engineering, and the use of immune cells to promote tissue repair and regeneration in conditions like spinal cord injuries and organ damage.

Track 8: Allergy and Hypersensitivity: Mechanisms and Treatments

Dive into the mechanisms underlying allergic reactions and hypersensitivity disorders, and explore the latest treatment approaches. This session covers everything from food and environmental allergies to novel immunotherapies targeting IgE-mediated pathways.

Track 9: Neuroimmunology and Brain-Immune Interactions

Investigate the growing field of neuroimmunology, focusing on the interactions between the immune system and the central nervous system. This session discusses the immune role in neurodegenerative diseases like Alzheimer's and multiple sclerosis and potential therapeutic interventions.

Track 10: Microbiome and Immune System Interactions

Understand the critical relationship between the human microbiome and immune system function. This session explores how gut microbiota influence immune responses and the development of microbiome-targeted therapies to modulate immunity and treat diseases.

Track 11: Immunotherapy in Autoimmune Neurological Disorders

This session focuses on immunotherapy's application in treating autoimmune neurological disorders such as multiple sclerosis, myasthenia gravis, and neuromyelitis optica. Learn about novel therapeutic strategies that target immune pathways to manage these challenging conditions.

Track 12: Immunotherapeutic Approaches in Transplantation

Examine the latest advances in immunosuppressive therapies and immune tolerance in organ transplantation. This session covers strategies to prevent graft rejection, minimize immunosuppression, and promote long-term transplant success through immune regulation.

Track 13: Immunotherapy for Chronic Inflammatory Diseases

Chronic inflammation is a key driver in many diseases, from arthritis to cardiovascular conditions. This session explores the latest research on immunotherapeutic approaches that target chronic inflammatory pathways to manage and treat these conditions.

Track 14: Immune Checkpoint Inhibitors: Expanding Horizons

Explore the latest developments in immune checkpoint inhibitors, which have revolutionized cancer treatment. This session focuses on expanding their use beyond oncology, investigating their potential in treating autoimmune diseases, infectious diseases, and chronic inflammation.

Track 15: Biomarkers in Immunotherapy: Predictive and Prognostic Tools

Discover how biomarkers are transforming immunotherapy by providing predictive and prognostic insights. This session covers the latest advancements in biomarker discovery, their role in patient stratification, and how they are guiding treatment decisions in cancer and autoimmune diseases.

Track 16: Nanotechnology in Immunotherapy

Nanotechnology offers exciting possibilities for improving immunotherapy delivery and efficacy. This session discusses the use of nanoparticles in vaccine delivery, cancer immunotherapy, and targeted drug delivery, highlighting recent innovations in nanomedicine.

Track 17: Pediatric Immunology and Immunotherapy

This session focuses on the unique challenges and advancements in pediatric immunology and immunotherapy. Topics include the development of immunotherapeutic approaches for childhood cancers, congenital immune disorders, and pediatric autoimmune diseases.

Track 18: Cellular Therapies in Immunotherapy

Explore the cutting-edge field of cellular immunotherapies, including CAR-T cells, TCR-T cells, and NK cell therapies. This session covers the latest advancements, clinical trials, and challenges in using cellular therapies to treat cancer, autoimmune diseases, and infections.

Track 19: Gene Editing and Immunotherapy

Gene editing technologies, such as CRISPR-Cas9, are revolutionizing immunotherapy by enabling precise modifications of immune cells. This session discusses the latest breakthroughs in gene editing for enhancing immune responses, including applications in cancer, genetic diseases, and infectious diseases.

Track 20: Regulatory and Ethical Challenges in Immunotherapy

As immunotherapy advances rapidly, regulatory and ethical challenges become more complex. This session addresses issues related to clinical trials, patient access, regulatory approvals, and the ethical implications of emerging therapies, providing a forum for discussion and policy development.

 

Abstract Submission Guidelines

  • Abstracts can be submitted through the online link ABSTRACT SUBMISSION
  • Abstracts must be submitted in English and should be within 250-300 words along with a biography of the presenter of 60-70 words
  • Submissions are welcome in all topics related to Allergy and Immunology.
  • Presenting author shall provide the following details: Full name of the presenter, Affiliation details: department, institution/hospital, country, Phone number & E-mail address and photograph
  • For Co-authors following details are required: Full names and affiliation details like department, institute/ organization name, and country shall be included
  • All abstracts will be reviewed by a review panel approved by the Immunology Meet 2024 Conference Review Committee.
  • All presenters of accepted abstracts will be required to register and pay for attendance at the Conference.

Visa Guidelines

Immunology Meet 2024 organizing committee hereby reiterates that we are NOT involved in VISA processing. We can assist by providing supporting documents like a Letter of invitation, Letter of Abstract Acceptance and Registration Payment Receipt.

You may be required to submit additional documents along with these documents to the embassy.

Letter of Invitation: The official Letter of Invitation is proof that your submitted paper and registration application are accepted by the conference committee board. It will be stated in English and may help you with your visa application.

Only registered participants will get an official letter of invitation

Attendees need to finish Registration & Authenticated information submission to get an official letter of invitation [i.e., Passport (Scan copy), DOB, Mobile Number, Physical Address and Photograph].

Contact the program manager for more information

Official Letters of Invitation will be provided only to attend the conference.

Participation Options

  • Keynote speaker: 45-50 minutes
  • Speaker (oral presentation): 25-30 minutes
  • Speaker (workshop): 45-50 minutes
  • Speaker (special session): 45-50 minutes
  • Delegate (only registration): Will have access to all the sessions with all the benefits of registration
  • Poster presenter : Can present a poster and enjoy the benefits of delegate
  • Remote attendance:  Can participate via video presentation or e-poster presentation
  • Exhibitor: Can exhibit his/her company’s products by booking exhibitor booths of different sizes
  • Media partner
  • Sponsor
  • Collaborator

Past Conference report

We extend our heartfelt thanks to all our distinguished speakers and attendees who contributed to making the Immunology Meet 2023 Conference an extraordinary success!

Held on November 16-17, 2023, in Paris, France, the 4th International Conference on Immunology and Immunotherapy, hosted by Conference Series LLC LTD, was themed “Part of Immune System towards Immunology and Immunotherapy.” Our goal was to create a premier international forum for medicinal researchers, immunologists, and healthcare professionals. We are grateful for the enthusiastic participation of Editorial Board Members of Conference Series Journals, pediatric nurses, doctors, pharmaceutical industry experts, researchers, and students from diverse fields, all of whom played a crucial role in the event’s success.

The conference featured a range of sessions addressing key scientific topics, including:

  • Immunology
  • Clinical Immunology & Current & Future Research
  • Molecular Immunology
  • Tumor Immunology
  • Mucosal Immunology
  • Transplant Immunology
  • Neuroimmunology
  • Immuno-Dermatology
  • Immuno-Genetics
  • Immunoinformatics & Systems Immunology
  • Infections & Disease
  • Allergy & Therapies
  • Eco-Immunology & Behavioral Immunity
  • Immune Disorders
  • Reproductive Immunology
  • T & B Cell Biology
  • Neonatal & Pediatric Immunology
  • Immunomodulators & Their Side Effects
  • Monoclonal Antibodies: Targeted Therapy
  • Role of Nanomedicine in Immunotherapeutics
  • Regenerative Immunity
  • Cytokine-Based Immunotherapy
  • Immunity Biological Processes

Building on the success of Immunology Meet 2023, we are excited to announce the 5th International Conference on Immunology and Immunotherapy, scheduled for December 12-13, 2024, in Zurich, Switzerland [Hybrid Event].

We look forward to seeing you at Immunology Meet 2024!

To Collaborate Scientific Professionals around the World

Conference Date December 12-13, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Immunogenetics: Open Access Immunochemistry & Immunopathology Journal of Clinical and Cellular Immunology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by